Flu

·MeSH: Influenza, Human
214 drugs in development·65 companies·1 clinical trial

Drug Pipeline by Phase

Approved(59)
DrugCompany
ak-fluorAKORN INC (AKRX)
alymsysAmneal Pharmaceuticals, Inc. (AMRX)
amoxicillinAptinyx Inc. (APTX)
amoxicillinMiromatrix Medical Inc. (MIRO)
amoxicillinSUNSET ISLAND GROUP (SUN)
avlayahDenali Therapeutics Inc. (DNLI)
banlangen granulesFuss Brands Corp. (FBDS)
bijuvaTherapeuticsMD, Inc. (TXMD)
BinaxNOW® / Panbio® rapid testing platformsABBOTT LABORATORIES (ABT)
ceftriaxoneTeva Pharmaceutical Industries Limited (TEVA)
ciprofloxacinANI PHARMACEUTICALS INC (ANIP)
ciprofloxacinAMARIN CORP PLCUK (AMRN)
ciprofloxacinDR REDDYS LABORATORIES LTD (RDY)
ciprofloxacinAltamira Therapeutics Ltd. (CYTOF)
ciprofloxacinSUNSET ISLAND GROUP (SUN)
ciprofloxacinPrestige Consumer Healthcare Inc. (PBH)
clarithromycinSUNSET ISLAND GROUP (SUN)
dexlansoprazoleMylan II B.V. (MYL)
Double - Coptis SuppositoryChina Health Industries Holdings, Inc. (CHHE)
Double-Coptis SuppositoryChina Health Industries Holdings, Inc. (CHHE)
famotidineSUNSET ISLAND GROUP (SUN)
famotidineENGENE HOLDINGS INC. (ENGN)
famotidineMiromatrix Medical Inc. (MIRO)
famotidineAvita Medical Inc. (RCEL)
famotidineSeagen Inc. (SGEN)
famotidineMersana Therapeutics, Inc. (MRSN)
fluconazoleANI PHARMACEUTICALS INC (ANIP)
fluocinonideAmneal Pharmaceuticals, Inc. (AMRX)
fluoresceinNEXUS BIOPHARMA INC (NEXS)
fluorometholoneAmneal Pharmaceuticals, Inc. (AMRX)
fluphenazineDR REDDYS LABORATORIES LTD (RDY)
ID NOW® rapid molecular systemABBOTT LABORATORIES (ABT)
Influvac™ABBOTT LABORATORIES (ABT)
inFoods® (IBS)BIOMERICA INC (BMRA)
krazatiBRISTOL MYERS SQUIBB CO (BMY)
leucovorin calcium preservative freeMylan II B.V. (MYL)
leucovorin calcium preservative freeSeagen Inc. (SGEN)
luvoxANI PHARMACEUTICALS INC (ANIP)
neoprofenUltragenyx Pharmaceutical Inc. (RARE)
ONAPGOSUPERNUS PHARMACEUTICALS, INC. (SUPN)
oralstatAMERICAN BIO MEDICA CORP (ABMC)
pantoprazoleSUNSET ISLAND GROUP (SUN)
pantoprazoleEXELIXIS, INC. (EXEL)
Poly-Vi-FlorAYTU BIOPHARMA, INC (AYTU)
potassiumNEXUS BIOPHARMA INC (NEXS)
propafenoneMylan II B.V. (MYL)
qing re jie du oral liquidFuss Brands Corp. (FBDS)
rapivabBIOCRYST PHARMACEUTICALS INC (BCRX)
RAPIVAB (peramivir injection)BIOCRYST PHARMACEUTICALS INC (BCRX)
sodium chloride 0.9% in plastic containerFresenius Medical Care AG American Depositary Shares (Each representing 1/2 of an Ordinary Share) (FMS)
teriflunomideAptinyx Inc. (APTX)
teriflunomideMersana Therapeutics, Inc. (MRSN)
tioproninAmneal Pharmaceuticals, Inc. (AMRX)
Tri-Vi-FlorAYTU BIOPHARMA, INC (AYTU)
vasopressinAmphastar Pharmaceuticals, Inc. (AMPH)
VOQUEZNAPhathom Pharmaceuticals, Inc. (PHAT)
vyalevAbbVie Inc. (ABBV)
vykouraKaya Holdings, Inc. (KAYS)
zaltrapSanofi (SNY)
Phase 3(38)
DrugCompany
biological/vaccineBioNTech SE (BNTX)
CD388Cidara Therapeutics, Inc. (CDTX)
COVID-19 VaccineBioNTech SE (BNTX)
cycloferonNYMOX PHARMACEUTICAL CORP (NYMXF)
d961hASTRAZENECA PLC (AZN)
d961hASTRAZENECA PLC (AZN)
d961h sachetASTRAZENECA PLC (AZN)
high-dose influenza vaccine (split virionSanofi (SNY)
high-dose quadrivalent influenza vaccineSanofi (SNY)
high-dose trivalent influenza vaccine (split virionSanofi (SNY)
Influenza and COVID-19 Combination ABioNTech SE (BNTX)
Influenza and COVID-19 Combination BBioNTech SE (BNTX)
Investigational COVID-19 VaccineBioNTech SE (BNTX)
Investigational Influenza VaccineBioNTech SE (BNTX)
Licensed COVID-19 VaccineBioNTech SE (BNTX)
Licensed influenza vaccineBioNTech SE (BNTX)
Licensed Influenza Vaccine 1BioNTech SE (BNTX)
Licensed Influenza Vaccine 2BioNTech SE (BNTX)
Licensed Influenza Vaccine 3BioNTech SE (BNTX)
Licensed Quadrivalent Inactivated Seasonal Influenza VaccineModerna, Inc. (MRNA)
mrna-1018-h5Moderna, Inc. (MRNA)
quadrivalent inactivated influenza vaccineSanofi (SNY)
quadrivalent influenza vaccineSanofi (SNY)
quadrivalent influenza vaccine (split virionSanofi (SNY)
quadrivalent recombinant influenza vaccineSanofi (SNY)
recombinant influenza vaccineSanofi (SNY)
standard-dose inactivated influenza vaccine quadrivalentSanofi (SNY)
standard-dose influenza virus surface antigensSanofi (SNY)
standard-dose quadrivalent influenza vaccineSanofi (SNY)
standard-dose trivalent influenza vaccine (split virionSanofi (SNY)
TEV-48574 Dose Regimen ASanofi (SNY)
trivalent influenza vaccine 1 sp shz tiv1Sanofi (SNY)
trivalent influenza vaccine 2 sp shz tiv2Sanofi (SNY)
trivalent recombinant influenza vaccineSanofi (SNY)
VonoprazanPhathom Pharmaceuticals, Inc. (PHAT)
vonoprazan (VOQUEZNA)Phathom Pharmaceuticals, Inc. (PHAT)
vonoprazan (VOQUEZNA) - as-needed regimenPhathom Pharmaceuticals, Inc. (PHAT)
vonoprazan (VOQUEZNA) - EoEPhathom Pharmaceuticals, Inc. (PHAT)
Phase 2(30)
Phase 1(40)
DrugCompany
alvr106Kalaris Therapeutics, Inc. (KLRS)
augment-tasmania influenza vaccineSanofi (SNY)
CC-42344Cocrystal Pharma, Inc. (COCP)
control vaccine older adultsArcturus Therapeutics Holdings Inc. (ARCT)
control vaccine younger adultsArcturus Therapeutics Holdings Inc. (ARCT)
furoscixscPharmaceuticals Inc. (SCPH)
h3 mrna / lnp vaccineSanofi (SNY)
high dose quadrivalent influenza vaccineSanofi (SNY)
Influenza A/Texas/71/2017UNITED THERAPEUTICS Corp (UTHR)
intranasal influenza vaccineMYMETICS CORP (MYMX)
LUNAR-FLU (seasonal influenza candidate)Arcturus Therapeutics Holdings Inc. (ARCT)
LUNAR-H5N1Arcturus Therapeutics Holdings Inc. (ARCT)
MF59Valneva SE (VALN)
MF59Cidara Therapeutics, Inc. (CDTX)
mrna na vaccineSanofi (SNY)
mRNA-1010Moderna, Inc. (MRNA)
mRNA-1345Moderna, Inc. (MRNA)
ocu520Ocugen, Inc. (OCGN)
quadrivalent riv with 2018-2019 nh h3 strainSanofi (SNY)
quadrivalent riv with h3 strain 1Sanofi (SNY)
quadrivalent riv with h3 strain 2Sanofi (SNY)
quadrivalent riv with h3 strain 3Sanofi (SNY)
quadrivalent riv with h3 strain 4Sanofi (SNY)
rsv vaccine 1Sanofi (SNY)
rsv vaccine 2Sanofi (SNY)
rsv vaccine formulation 1 doseSanofi (SNY)
rsv vaccine formulation 2 doseSanofi (SNY)
rsv vaccine formulation 3 doseSanofi (SNY)
rsv vaccine formulation 4 doseSanofi (SNY)
rsv vaccine formulation 5 doseSanofi (SNY)
rsv vaccine formulation 6 doseSanofi (SNY)
rsv vaccine formulation 7 doseSanofi (SNY)
rsv vaccine formulation 8 doseSanofi (SNY)
rsv/hmpv/piv3 vaccineSanofi (SNY)
scp-111scPharmaceuticals Inc. (SCPH)
SER-252SUPERNUS PHARMACEUTICALS, INC. (SUPN)
tiv-2x darwin influenza vaccineSanofi (SNY)
trivalent-darwin influenza vaccineSanofi (SNY)
trivalent-tasmania influenza vaccineSanofi (SNY)
VRC-FLUMOS0116-00-VPCidara Therapeutics, Inc. (CDTX)
Phase 1/Phase 2(20)

Compare drugs

Frequently asked questions

How many drugs are in development for Flu?

BioSniper tracks 214 drugs in development for Flu across 65 companies.

How many clinical trials target Flu?

There are 1 clinical trial targeting Flu tracked by BioSniper.

Deep-dive into Flu

Full trial data, competitive analysis, and AI-powered pipeline tracking.

Start Free Analysis